Table 2.
Vaccine target | Product name | Company involved | Date licensed and country |
Target organisms |
Benefits |
---|---|---|---|---|---|
West Nile virus | West Nile Innovator |
Centers for Disease Control and Prevention and Fort Dodge Laboratories |
2005 USA | Horses | Protects against West Nile virus infection |
Infectious haematopoietic necrosis virus |
Apex-IHN | Novartis | 2005 Canada | Salmon | Improves animal welfare, increase food quality and quantity |
Growth hormone releasing hormone |
LifeTide-SW5 | VGX Animal Health | 2007 Australia | Swine and food animals* |
Increases the number of piglets weaned in breeding sows; significantly decreases perinatal mortality and morbidity |
Melanoma | Canine Melanoma Vaccine |
Merial, Memorial Sloan–Kettering Cancer Center and The Animal Medical Center of New York |
2007 USA, conditional license |
Dogs | Treats aggressive forms of cancer of the mouth, nail bed, foot pad or other areas as an alternative to radiation and surgery |
Refers to agricultural animals as opposed to pet animals — a higher level of stringency is required for approval for animals that are part of the food chain.